{"podcast":{"title":"The Bottom Line","slug":"the-bottom-line-1067438","podcast_index_feed_id":1067438,"rss_url":"https://podcasts.files.bbci.co.uk/b006sz6t.rss","website_url":"http://www.bbc.co.uk/programmes/b006sz6t","image_url":"http://ichef.bbci.co.uk/images/ic/3000x3000/p0lj0v13.jpg","author":"BBC","episode_count":428,"summary":"Evan Davis hosts the business conversation show with people at the top giving insight into what matters","last_synced_at":"2026-06-12T00:17:34.720641+00:00","page_url":"https://stenobird.com/podcast/the-bottom-line-1067438"},"episode":{"title":"Decisions That Made Me: Harry Destecroix (Ziylo, Science Creates, SCVC)","slug":"decisions-that-made-me-harry-destecroix-ziylo-science-creates-scvc","published_at":"2025-12-04T12:30:00+00:00","page_url":"https://stenobird.com/podcast/the-bottom-line-1067438/decisions-that-made-me-harry-destecroix-ziylo-science-creates-scvc","show_page_url":"https://stenobird.com/podcast/the-bottom-line-1067438","url":"http://www.bbc.co.uk/programmes/p0mljdfv","audio_url":"http://open.live.bbc.co.uk/mediaselector/6/redir/version/2.0/mediaset/audio-nondrm-download-rss/proto/http/vpid/p0mlhnn0.mp3","summary":"Harry Destecroix was studying for his PhD at Bristol University when he co-founded Ziylo. Based on 20 years of Bristol chemistry research, the spin-out company created a new technology that can be developed to treat diabetes more effectively. It's a breakthrough that led to its acquisition by pharmaceutical firm, Novo Nordisk, in a deal reportedly worth up to 600 million pounds. Harry has also founded the incubator, Science Creates and is the founding managing partner of SCVC, a venture capital firm. Harry tells Evan Davis why his own experience of spinning out a company has made him passionate to help other early-stage companies in the Bristol area – whether that’s providing lab space, finance or advice. (Image: Harry Destecroix Credit: Peter Schiazza, Copyright: Science Creates)","meta_description":"Harry Destecroix was studying for his PhD at Bristol University when he co-founded Ziylo. Based on 20 years of Bristol chemistry research, the spin-out co…","key_points":[],"chapters":[],"topics":[],"duration_seconds":866,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/the-bottom-line-1067438/episodes/decisions-that-made-me-harry-destecroix-ziylo-science-creates-scvc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/the-bottom-line-1067438/decisions-that-made-me-harry-destecroix-ziylo-science-creates-scvc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}